Skip to main content
editor.ajphr@gmail.com
9409046853
e-ISSN: 2321-3647
American Journal of Pharmacy and Health Research

American Journal of Pharmacy and Health Research

Published

Dapagliflozin Induced Severe Pruritis – A Rare Adverse Drug Reaction

Published in October 2025 Issue 10 (Vol. 13, Issue 10, 2025)

Dapagliflozin Induced Severe Pruritis – A Rare Adverse Drug Reaction - Issue cover

Abstract

ABSTRACTDapagliflozin is an SGLT2 inhibitor that is used to treat type 2 diabetes, as well as those with heart failure and chronic renal disease. We report a case report of a 57-year-old male diabetic who presented with severe pruritis which was later found to be due to dapagliflozin and was totally subsided after discontinuing dapagliflozin. Keyword: SGLT2 inhibitor - Selective sodium-glucose transporter-2 inhibitor.

Citations & discovery

Explore citations to this article and find it in scholarly databases.

Crossref
…
Citations
View record
Europe PMC
…
DOI matches
View results
Google Scholar

Checking citation sources…

Citation counts reflect each source's coverage. Europe PMC shows DOI search matches, including mentions in references. Article lists may be incomplete. Google Scholar opens a separate search.

Download Article

PDF

Best for printing and citation

File size: 0.0 MB
Format: PDF

Summarise this paper with AI:

Article Information

AJPHR1310001

AJPHR-01-000900

1-4

2025-10-01

JATS XML

Article Impact

Views:1,781
Downloads:752
scite_
PlumX Metrics Badge

How to Cite

Rachel Biji, N., S.K Mathew, D., Josey, D., & John, J. (2025). Dapagliflozin Induced Severe Pruritis – A Rare Adverse Drug Reaction. American Journal of Pharmacy and Health Research, 13(10), 1-4. https://doi.org/10.5281/zenodo.17875587

Article Actions

Whatsapp